Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
-
BookingCentral Launches AI Connector, Letting Rental and Tour Operators Ask Claude or ChatGPT About Their Fleet, Bookings and Customers in Plain English
-
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
-
Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field
-
EXL schedules third quarter 2026 financial results conference call
-
Safe Pro Expects Record 2,300% Revenue Growth in Q3 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping
-
Skyworks Si829x Isolated Safety Gate Driver Qualified and Ready for Customer Evaluation
-
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
-
AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026
-
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
-
American Fusion Restructures Up to $2.88 Million of Stock-Based Compensation Obligations into Long-Term, Lock-Up Preferred Equity and Begins Auditor Transition to MBP Global LLP
-
SEON Appoints Ken Talanian as Chief Financial Officer
-
Magnum York and C-Era Tee Up to Support Families in Crisis Through Associa Cares Canada
-
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
-
Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy
-
Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth
-
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
-
AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base
-
Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live
-
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
-
Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness
-
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
-
Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results
-
Madison Realty Capital Provides Loan for Hotel Washington in Washington, D.C.
-
WillScot Elects Donald Slager to Board of Directors
-
ZeroMe Launches OffsetC App to Bring Transparency and Personal Agency to Carbon Offsetting
-
Clearsense Introduces Cloud Medical Image Archive to Reduce Infrastructure and Storage Costs
-
Virtu Financial to Host Conference Call Announcing Third Quarter 2026 Results on Thursday, November 5, 2026
-
Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development
-
Texas Capital Bancshares, Inc. Announces Date for Q3 2026 Operating Results
-
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
-
Skyharbour Commences Drilling at the Getty East Uranium Joint Venture with Partner Denison Mines at the Russell Lake Project Area
-
Nuclear Waste Innovator Deep Isolation to Present at Three Upcoming Investor Conferences
-
Sunrun Announces Date for Third Quarter 2026 Earnings Report
-
Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide
-
Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Bitcoin Learns to Move: IBVM Lists on MEXC as TOKEN2049 Comes to Singapore
-
New MIT Sloan research finds a “Bamboo Ceiling” for ethnic Chinese men in the UK
-
Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference
-
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
-
New Purpose Unlimited research reveals Canadians are more financially ambitious than the system they’ve been handed
-
Volatus Aerospace Completes the Initial ISR Drone Fleet Delivery to NATO Partner
-
Hillman Sets Third Quarter 2026 Earnings Release and Results Presentation Date
-
Crane NXT Appoints Jeong H. Kim to Board of Directors
-
Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets
-
Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer
-
Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations
-
BrewDog Rallies Beer Lovers Across the UK to Choose Craft
-
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
